These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21434892)

  • 1. Cholesterol-lowering strategies reduce vascular LRP1 overexpression induced by hypercholesterolaemia.
    Llorente-Cortes V; Casani L; Cal R; Llenas A; Juan-Babot O; Camino-López S; Sendra J; Badimon L
    Eur J Clin Invest; 2011 Oct; 41(10):1087-97. PubMed ID: 21434892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of efficacy of tibolone and simvastatin on atherosclerosis in ovariectomized cholesterol-fed rabbits.
    Cui Y; Zhao D; Liu H; Ning Z; Yang J; Qing X; Yu S; Wu C
    Maturitas; 2005 Apr; 50(4):337-43. PubMed ID: 15780535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
    Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
    J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.
    Luo L; Zheng YF; Dai Y; Dai DZ
    J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis.
    Nachtigal P; Kopecky M; Solichova D; Zdansky P; Semecky V
    J Pharm Pharmacol; 2005 Feb; 57(2):197-203. PubMed ID: 15720783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects.
    Bauersachs J; Hiss K; Fraccarollo D; Laufs U; Ruetten H
    Cardiovasc Res; 2006 Dec; 72(3):438-46. PubMed ID: 17026973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study.
    Henry GD; Byrne R; Hunyh TT; Abraham V; Annex BH; Hagen PO; Donatucci CF
    Int J Impot Res; 2000 Dec; 12(6):334-9. PubMed ID: 11416837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
    Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
    Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering.
    Wilson SH; Herrmann J; Lerman LO; Holmes DR; Napoli C; Ritman EL; Lerman A
    Circulation; 2002 Jan; 105(4):415-8. PubMed ID: 11815421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
    Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
    Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha lipoic acid possess dual antioxidant and lipid lowering properties in atherosclerotic-induced New Zealand White rabbit.
    Zulkhairi A; Zaiton Z; Jamaluddin M; Sharida F; Mohd TH; Hasnah B; Nazmi HM; Khairul O; Zanariyah A
    Biomed Pharmacother; 2008 Dec; 62(10):716-22. PubMed ID: 18538528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan.
    Chen H; Li D; Sawamura T; Inoue K; Mehta JL
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1100-4. PubMed ID: 11027596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular effects of diet and statin in hypercholesterolemic patients.
    Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Choi YM; Ahn TH; Kim DS; Shin EK
    Int J Cardiol; 2004 Jun; 95(2-3):185-91. PubMed ID: 15193818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early intervention on atherosclerosis by fluvastatin and lectin-like oxidized low-density lipoprotein receptor-1 expression in atherosclerotic arteries in immature rabbits].
    Yu YH; Wang Y; Chen Y; Liu ZZ; Sun SZ; Meng XH
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):762-6. PubMed ID: 16255856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH).
    MacMahon M; Kirkpatrick C; Cummings CE; Clayton A; Robinson PJ; Tomiak RH; Liu M; Kush D; Tobert J
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):195-203. PubMed ID: 11079257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.